Cabot Corp

Cabot Corp(CBT)の株式分析

$74.020

+1.155 (+1.56%)終値時点

Loading chart…
高値
74.370
始値
73.280
出来高加重平均価格
73.70
出来高
392.94K
時価総額
5.16B
安値
72.710
売買代金
28.96M
EV/EBITDA(TTM)
6.69

Cabot Corporation is a global specialty chemicals and performance materials company. The Company's principal products are reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants and aerogel. It operates through two segments: Reinforcement Materials and Performance Chemicals. Its reinforcing carbon products are used in tires and industrial products. In addition to its reinforcing carbons, it manufactures engineered elastomer composites (E2C) solutions that are composites of reinforcing carbons and rubber made using its patented elastomer composites manufacturing process. Under the Performance Chemicals segment, it designs, manufactures and sells materials that deliver performance in a range of customer applications across the automotive, construction, infrastructure, inkjet printing, electronics, and consumer products sectors and in applications related to the generation, transmission and storage of energy.

www.cabotcorp.com

AI分析 of Cabot Corp (CBT)

中立

Cabot Corp is currently a hold. The stock is priced at $73.79, which is below the average analyst target of $92, indicating potential upside. However, the RSI is at 36.267, suggesting it is nearing oversold territory, but the recent earnings report showed a significant drop in net income to $6 million, down from $101 million last year, which raises concerns about profitability.

アナリスト評価(7)

-10.39% 下落余地
中立
3 買い
4 中立
0 売り
現在: 74.02
安値
54.00
平均
66.33
高値
80.00

UBS

2026-10-05

目標株価

$86

中立

Truist

2026-08-05

目標株価

$100

買い

Mizuho

2026-06-25

目標株価

$90

中立

JPMorgan

2026-05-13

目標株価

$70

アンダーウェイト

UBS

2026-05-08

目標株価

$86

中立

バリュエーション指標

Cabot Corp(CBT)の現在の予想PERは9.94で、5年平均は11.17です。

予想PER

適正
5年平均 P/E
11.17
現在のP/E
9.94
割高
12.58
割安
9.76

予想EV/EBITDA

適正
5年平均 EV/EBITDA
6.96
現在のEV/EBITDA
6.69
割高
7.63
割安
6.30

予想PSR

適正
5年平均 P/S
1.05
現在のP/S
1.00
割高
1.22
割安
0.89

Alphio AI による CBT の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%CBT

$73.88

シナリオ価格

基

基本

基本 · 50%CBT

$69.19

シナリオ価格

弱

弱気

弱気 · 25%CBT

$55.14

シナリオ価格

CBT を保有するクジラ

S

Snyder Capital Management, L.P.

+ を保有CBT

+6.08%

3か月リターン

F

Fiduciary Trust Company

+ を保有CBT

-1.22%

3か月リターン

E

EARNEST Partners, LLC

+ を保有CBT

-5.02%

3か月リターン

イベントタイムライン

2026-09-17 (ET)

09:30:00

Cabot Secures $50M Grant from DOE

2026-09-15 (ET)

09:00:00

Cabot Appoints Steve Delahunt as Interim CFO

2026-08-03 (ET)

17:00:00

Company Adjusts Fiscal 2026 EPS Guidance to $6.15-$6.45

17:00:00

Cabot Reports Q3 Revenue of $982M, Beating Expectations

2026-05-05 (ET)

16:50:00

Cabot Reports Q2 Revenue of $904MM, Beating Expectations

ニュース

CBT のよくある質問 — Alphio AI が回答

Cabot Corporation is a global specialty chemicals and performance materials company. The Company's principal products are reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants and aerogel. It operates through two segments: Reinforcement Materials and Performance Chemicals. Its reinforcing carbon products are used in tires and industrial products. In addition to its reinforcing carbons, it manufactures engineered elastomer composites (E2C) solutions that are composites of reinforcing carbons and rubber made using its patented elastomer composites manufacturing process. Under the Performance Chemicals segment, it designs, manufactures and sells materials that deliver performance in a range of customer applications across the automotive, construction, infrastructure, inkjet printing, electronics, and consumer products sectors and in applications related to the generation, transmission and storage of energy. It operates in the Basic Materials sector (MISCELLANEOUS CHEMICAL PRODUCTS industry).

Cabot Corp is currently a hold. The stock is priced at $73.79, which is below the average analyst target of $92, indicating potential upside. However, the RSI is at 36.267, suggesting it is nearing oversold territory, but the recent earnings report showed a significant drop in net income to $6 million, down from $101 million last year, which raises concerns about profitability.

7 analysts cover CBT: 3 rate it Buy, 4 Hold and 0 Sell. The average price target is 66.33.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める